Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
ABVCAbvc Biopharma, Inc.
| Figure | ABVCAbvc Biopharma, Inc.FY2025 · Dec |
|---|---|
| Revenue | $296.00K |
| Revenue, yoy | −41.9% |
| Net income | $7.91M |
| Net income, yoy | −61.3% |
| Net margin | -2,671.8% |
| Free cash flow | $4.21M |
| FCF margin | — |
| EPS, diluted | $0.39 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed